| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $31.0M | -40.8% |
| SG&A Expense | $20.2M | -3.5% |
| Operating Income | -$51.2M | +30.2% |
| Interest Expense | $11.6M | +60.8% |
| Pre-tax Income | -$62.3M | +22.7% |
| Income Tax | $70K | — |
| Net Income | -$62.2M | +22.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | -78.5% |
| Short-term Investments | $27.3M | -46.8% |
| Current Assets | $38.5M | -50.2% |
| Total Assets | $44.0M | -47.1% |
| Current Liabilities | $13.4M | +3.4% |
| Total Liabilities | $153.2M | +8.4% |
| Stockholders' Equity | -$109.2M | -88.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.4M | +36.1% |
| Capital Expenditures | $25K | -91.2% |
| Investing Cash Flow | $24.0M | +358.1% |
| Financing Cash Flow | $3.9M | -94.2% |
| Free Cash Flow | -$43.5M | +36.3% |